University Medical Center Nijmegen st Raboud

Site:	University Medical Center Nijmegen st Raboud
Address:
City:	Nijmegen
State:	Gelderland
Zip:	6525 GH
Country:	Netherlands

Phase	Trial	Trial Status	Site Status	Drug [asc]	NCT#
4	Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors	Unknown	Active		NCT00777504
3	(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors	Recruiting	Active	Bezuclastinib plus Sunitinib	NCT05208047
3	Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stromal Tumor That is Responding to Imatinib Mesylate	Terminated	Closed	Imatinib	NCT00956072
3	Three Versus Five Years of Adjuvant Imatinib as Treatment of Patients With Operable GIST	Active, not recruiting	Closed	Imatinib	NCT02413736
1	Influence of an Acidic Beverage on the Imatinib Exposure After Major Gastrectomy (ABILITY)	Terminated	Closed	Imatinib	NCT02185937
	GIST: Assessment of Tumor Mutations and TKI Plasma Exposure	Recruiting	Not yet activated	Imatinib + Sunitinib + Regorafenib	NCT02331914
	Study on the Influence of Sunitinib and Sorafenib on Fatigue, Quality of Life and Depression in Patients With Metastatic Renal Cell Cancer or Gastrointestinal Stromal Tumor (GIST)	Completed	Active	Sunitinib or Sorafenib	NCT00979329